Lingdan Chen
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
-
- Immune cells in cancer
Papers in
-
- Pulmonary Hypertension Research and Treatments 9
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
-
- COVID-19 Clinical Research Studies 3
- Co-authors
- Wenju Lu (16 shared papers)Neng Wang (5 shared papers)Baoping Yu (1 shared paper)Dan Xu (1 shared paper)He-Sheng Luo (1 shared paper)Mingjie Yuan (5 shared papers)Tao Lin (2 shared papers)Tao Wang (8 shared papers)
- Journals
- International Journal of Cardiology (4 papers)Biochemical and Biophysical Research Communications (2 papers)American Journal of Respiratory and Critical Care Medicine (2 papers)Bioscience Reports (2 papers)Life Sciences (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Lingdan Chen
26 papers receiving 546 citations
Lingdan Chen's Hit Papers
Peers
Comparison fields: 5 of 68
- Genetics 61
- Immunology 89
- Biochemistry 25
- Oncology 86
- Cancer Research 46
Countries citing papers authored by Lingdan Chen
This map shows the geographic impact of Lingdan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingdan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingdan Chen more than expected).
Fields of papers citing papers by Lingdan Chen
This network shows the impact of papers produced by Lingdan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingdan Chen. The network helps show where Lingdan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingdan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response Hit paper breakdown → | 2023 | 165 |
| 2 | 2021 | 101 | |
| 3 | 2020 | 40 | |
| 4 | 2008 | 39 | |
| 5 | 2012 | 31 | |
| 6 | 2018 | 23 | |
| 7 | 2017 | 22 | |
| 8 | 2023 | 21 | |
| 9 | 2019 | 18 | |
| 10 | 2020 | 17 | |
| 11 | 2014 | 14 | |
| 12 | 2022 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2020 | 10 | |
| 15 | 2018 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2021 | 5 | |
| 18 | 2020 | 4 | |
| 19 | 2018 | 3 | |
| 20 | 2018 | 3 |
About Lingdan Chen
Lingdan Chen is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Complementary and alternative medicine, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 28 papers that have together received 559 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (9 papers), Angiogenesis and VEGF in Cancer (4 papers), COVID-19 Clinical Research Studies (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Nitric Oxide and Endothelin Effects (2 papers), MicroRNA in disease regulation (2 papers), Peripheral Artery Disease Management (2 papers) and Traditional Chinese Medicine Analysis (2 papers). The work is most often cited by research in Genetics (61 citations), Immunology (89 citations), Biochemistry (25 citations), Oncology (86 citations) and Cancer Research (46 citations). Lingdan Chen has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Wenju Lu, Neng Wang, Baoping Yu, Dan Xu, He-Sheng Luo, Mingjie Yuan, Tao Lin, Tao Wang, Zhun Sun and Ping‐Hong Zhou. Their work appears in journals such as International Journal of Cardiology, Biochemical and Biophysical Research Communications, American Journal of Respiratory and Critical Care Medicine, Bioscience Reports and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.